Skip to content

Latest News

Zydus Life shares rise as US arm gains rights for rare paediatric disease drug

Zydus Life shares rise as US arm gains rights for rare paediatric disease drug

Zydus Lifesciences#39; arm has taken over the development and commercialization of CUTX-101, a product for treating Menkes disease Read More ​ Zydus Lifesciences#39; arm has taken over the development and commercialization of CUTX-101, a product for treating Menkes disease Zydus Lifesciences#39;… Read More »Zydus Life shares rise as US arm gains rights for rare paediatric disease drug

en_USEnglish